Deontics Clinical Futures

Meet the Team

Board of Directors

Dr. James Whitticase, MD


20 yrs. Medicine, entrepreneur specialising in medical technologies.

Dr. Guy Wood-Gush, MD

Chief Executive

A Deontics Founder, Guy worked as a neurosurgeon and ophthalmic surgeon before moving into healthcare investment banking and entrepreneurship and driving forward medical innovation.

Having qualified from Kings Collegel at the University of London and worked as a neurosurgeon and ophthalmic surgeon, Guy went to work in drug development with Eli Lilly.

Following this, he went to INSEAD in France to complete an MBA, before spending 11 years in healthcare investment banking. The first five years were as a healthcare stock analyst at Barclays de Zoete Wedd, followed by 6 years as a healthcare corporate financier with Robert Fleming and JPMorgan. For the last eight years, he has been working as an entrepreneur, bringing new medical innovations to market. This experience has included being CEO of technology transfer at the Cancer Research Campaign (now Cancer Research UK), the leading cancer focused technology transfer company in the world, and Executive Chairman of Cambridge Cognition Ltd. which floated successfully on the London Stock Exchange. Guy is a Deontics Founder.

Dr. Ioannis Chronakis, MD

Chief Technical Officer

A Deontics Founder, Ioannis developed pioneering software for space exploration, before specializing in medical software and decision support technology.

Ioannis holds an MD from the Medical School of University of Patras, Greece, where he also completed his internship. Shortly after, he switched focus to software engineering.

From 1999 to 2001, he acted as a technical director and software developer in a successful start-up Internet Service Provider (General Satellite Applications for the Internet, Patras).

Following this, he worked as senior software developer in a photo news agency (Reporter ltd, Athens), designing and implementing software and infrastructure for internet-based digital image collection, storage and distribution.

In 2003, Ioannis worked as a team leader/software engineer in Hellenic Technology of Robotics (Athens), where he developed the kernel, collision detection, virtual force field generator and communications modules for the Environment Dynamics Simulator project outsourced by the European Space Agency (ESTEC dept) and used for ground testing and programming of two of the robotic arms deployed in the International Space Station. He then assumed the role of the technical manager in the same company in 2005, for the commercial exploitation of space telemetry and control technology for ground systems (ANEMO project).

Since 2006, he has been working with Prof John Fox (Advanced Computation Laboratory in Cancer Research UK initially, University of Oxford engineering department subsequently) as a senior medical software developer. This has mainly involved the development of the Tallis/PROforma decision support technology and applications for cardiovascular and oncology diseases. Ioannis is a Deontics Founder.


Professor John Fox, PhD

Chief Scientific Officer

A Deontics Founder, John is a globally recognized scientist in medical informatics and a leading light in clinical decision support and pathways technologies.

After completing a PhD at Cambridge University, John spent a period in the USA at Carnegie Mellon University, returning to establish a research programme in clinical decision making for the Medical Research Council.

In 1981 he joined the Imperial Cancer Research Fund (now Cancer Research UK), where he built up a highly innovative team that developed a range of clinical technologies over subsequent years. In 1985 the group developed an “expert system” package which was commercialized as Xiplus by Expertech Ltd. Xiplus was widely used for business as well as medical applications, and for a period was the largest single source of commercial income for ICRF. Expertech was acquired by US-based Inference Corporation in 1990. In 1996, the group was awarded the Laureate Medal of the European Federation of Medical Informatics for work on PROforma, the first formal language and practical technology for supporting evidence-based decision-making and workflow management. John also conceived and co-founded InferMed Ltd (, acquired by Elsevier in 2015. Since 2007 John has been Director of the COSSAC collaboration between Oxford and Edinburgh Universities and UCL medical school (Royal Free Hospital), which is developing new generations of decision support technologies and applications. He is also Chairman of the OpenClinical clinical content community. John is a Deontics Founder.

John McMonigall

Non-Executive Director

A renowned investor in leading-edge technology and communications, John has been noted as one of Europe’s most successful technology investor for many years.

John served as a Divisional Managing Director of British Telecom Plc from 1985-1990 after a twenty-five-year career in software and electronics.

In 1990, he joined Apax Partners Worldwide LLP, where he was the senior partner responsible for investments in technology and telecommunications. Eight of his early stage investee companies were listed on public markets and many others were sold to major public and private corporations. According to the Apax institutional investors, he was Europe’s most successful technology investor for many years.

Dr. Nicholas Beard, MD

Non-Executive Director

A prominent senior healthcare executive, Nick has been a hospital CIO and is a part-time lecturer at leading universities.

Based in Seattle, Nick has over 30 years’ experience in the healthcare industry. He has held numerous senior executive positions, including at leading electronic patient records and clinical guidelines companies, working in the US, UK and other markets.

He has also been a hospital CIO. He was CMO and VP of Health Informatics and Product Marketing at IDX, which was sold to GE for $1.2bn, SVP Strategy at Milliman Clinical Guidelines, which was sold to Hearst for an undisclosed sum, and CMO at the Healthy Communities Institute, sold to Xerox Corporation.

While at IDX, Nick was the Principal Investigator on the SAGE project, which sought to develop a universal electronic clinical pathways technology, collaborating with Stanford University, the Mayo Clinic, the University of Nebraska and Intermountain Healthcare, a pioneer and leading US center in advanced Healthcare IT.

Nick has an extensive industry and academic network. He is Assistant Clinical Professor at Oregon Health & Science University, is a regular lecturer at the University of California at Berkeley, and has lectured at Stanford University’s Medical Informatics Department, the University of Washington, the National University of Singapore, and Glasgow University.

He qualified in medicine at St George’s Medical School, London, and has a Masters of Science degree in software engineering from Imperial College.

Senior Management

Dr. Vivek Patkar, MD, FRCS

Chief Medical Officer

A Deontics Founder, Vivek is a practising oncoplastic breast surgeon and a major interest in digital health.

Vivek Patkar is trained and experienced surgical oncologist with specialist interest and skills in breast cancer. He graduated in medicine from the University of Bombay in 1995 and was awarded his masters degree in general surgery (M.S. General Surgery) in 1999. Mr Patkar received training in surgical oncology and breast surgery at the TATA Memorial hospital, the largest tertiary cancer hospital and research centre in India. He practiced at TATA Memorial hospital for five years before coming to the United Kingdom to pursue his clinical and research interests. He has worked as specialist registrar in the breast unit at Guy’s hospital and at the Royal Free hospital in London and currently has clinical duties at the Whittington Hospital in London.

Mr. Patkar has a longstanding research interest in cancer informatics and he is clinical lead on the Deontics project. He is the designer and implementer of the Deontics breast cancer knowledge base at the Royal Free Hospital. He has also developed a large number of decision support applications for other indications. Mr Patkar is one of the founder members of the COSSAC collaboration between Oxford and Edinburgh Universities and UCL medical school (Royal Free Hospital) which is developing new generations of decision support technologies and applications. He is a Deontics Founder.

Dr. David Glasspool, PhD

Head of Knowledge Engineering

A Deontics Founder, David has deep academic and commercial experience in cognitive computing.

David has a PhD in Computational Neuroscience and Psychology from University College, London (UCL). David worked as a programmer for Logica plc for 3 years before moving into academia. His work at UCL, CRUK and the School of Informatics at Edinburgh University has included neural networks, decision-making, artificial intelligence and automated reasoning. David is the key inventor of the Deontics Authoring tool as well as being a leader in the development of the broader platform. David has been working with Professor Fox for 16 years and is a Deontics Founder.

Scientific Advisory Board

Professor Mor Peleg

Professor Mor Peleg, is a globally recognized scientist in the field of clinical pathways modelling at the Universities of Haifa and Stanford. She has been a faculty member at the Department of Information Systems at the University of Haifa, Israel, since 2003. Mor received her BSc and MSc in Molecular Biology from the Technion – Israel Institute of Technology, and a Ph.D. in Information Systems Engineering from the Faculty of Industrial Engineering at the Technion in 1999.

She completed a four-year post-doc fellowship at Stanford University Center for BioMedical Informatics, where she was also a visiting assistant professor during a sabbatical in 2007-9. In 2005, she was awarded the New Investigator Award by the American Medical Informatics Association (AMIA). Mor’s research concerns the development of methodologies and software tools for representing and analyzing complex bio-medical systems, with a focus on knowledge representation and learning of healthcare processes and clinical guideline-based decision support systems. Her research has appeared in such publications as JAMIA, JBI, Methods of Information in Medicine, International Journal of Medical Informatics, Bioinformatics, IEEE Transactions on Software Engineering, and Proceedings of the IEEE. She is a member of the editorial board of Methods of Information in Medicine, is the PC Chair of AIME 2011, and regularly co-chairs the PROhealth workshop and the Knowledge Representation for Healthcare workshop.

Professor Charles Vincent

Professor of Psychology, University of Oxford and Emeritus Professor of Clinical Safety Research, Imperial College, London.

Charles trained and worked as an NHS clinical psychologist before beginning his research career. In 1995 he established the Clinical Risk Unit at University College, where he was Professor of Psychology before moving to Imperial College in 2002. He is now Director of the Imperial Centre for Patient Safety and Service Quality (CPSSQ) and the Clinical Safety Research Unit, which is based in the Department of Surgery and Cancer. He is the editor of Clinical Risk Management (BMJ Publications, 2nd edition, 2001) and author of Patient Safety (2nd edition, 2010). From 1999 to 2003, he was a Commissioner on the UK Commission for Health Improvement. He is a Fellow of the Academy of Social Sciences and was recently reappointed as an NIHR Senior Investigator.

Dr. Fiona MacNeill

A Consultant Breast Surgeon at the Royal Marsden Hospital, London, Fiona MacNeill has been a specialist consultant breast and reconstructive surgeon since 1996. Her main interest is oncoplastic breast surgery – achieving the best outcomes in cancer surgery and breast appearance. She has lectured widely in the UK and Europe and was a founder of the first oncoplastic training programme.

Fiona is breast tutor at the Royal College of Surgeons, responsible for developing a national breast education and training portfolio. She has successfully delivered the national sentinel node training programme NEW START. Her achievements in education were recognized in 2006, when she was awarded the Silver Scalpel Trainer of the Year.

Fiona remains actively engaged in local and national research trials. She acts in an advisory capacity to a variety of Department of Health committees to optimise breast services and plan future cancer strategy. In addition, she is a member of a number of professional associations, most notably the Association of Breast Surgery (ABS @BASO), where she is Chair of the education and training committee.

Fiona qualified from St Bartholomew’s Hospital, London, in 1983 and was awarded an MD thesis in 1994 investigating novel breast cancer therapies. Appointed consultant surgeon in 1996 at Colchester, she established and led a highly successful breast unit before moving to The Royal Marsden in 2006.